Abbott has announced that U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinit...
US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year globa...
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market a...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with aut...
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...
Increasing prevalence of rare genetic disorders globally coupled with extensive applications of direct-to-consumer genet...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries p...
Lyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership with Gilead Science...
ImaginAb Inc., a US based clinical stage immuno-oncology imaging company has entered into a non-exclusive license and co...
Growing prevalence of chronic diseases such as high blood pressure, diabetes and cardiac diseases will drive mHealth mar...
Logmore is a Finnish start-up company with the first solution in the world to suit end-to-end monitoring. The company&rs...
Vanderbilt-Ingram Cancer Center and GenomOncology LLC announce the launch of the newly redesigned and improved My Cancer...
Fresenius Medical Care, the world’s largest provider of dialysis products and services, is expanding its clinical ...
The University of Oslo (UiO), International AIDS Vaccine Initiative (IAVI), and the Translational Health Science and Tec...
Varian, a US based leader in developing and delivering cancer care solutions, has announced it has signed an ...
FSD Pharma and Prismic Pharmaceuticals, a US-based specialty R&D pharmaceutical company has ann...
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...
